新型β-内酰胺类药物对脆弱拟杆菌及其他拟杆菌属临床分离株的活性。
Activity of newer beta-lactam agents against clinical isolates of Bacteroides fragilis and other Bacteroides species.
作者信息
O'Keefe J P, Venezio F R, DiVincenzo C A, Shatzer K L
机构信息
Infectious Disease Research Laboratory, Loyola University Medical Center, Maywood, Illinois 60153.
出版信息
Antimicrob Agents Chemother. 1987 Dec;31(12):2002-4. doi: 10.1128/AAC.31.12.2002.
Abstract
The in vitro activities of beta-lactam antibiotics against Bacteroides fragilis and B. fragilis group isolates are presented. Clinical isolates from 1986 were compared with strains from 1979 to 1982. Imipenem, ticarcillin-clavulanic acid, and ceftizoxime were the most active agents. Cefotetan was equivalent to cefoxitin against B. fragilis but less active against B. fragilis group isolates. Enhancement of cefotaxime by its desacetyl metabolite was minimal.
摘要
本文介绍了β-内酰胺类抗生素对脆弱拟杆菌及脆弱拟杆菌群分离株的体外活性。将1986年的临床分离株与1979年至1982年的菌株进行了比较。亚胺培南、替卡西林-克拉维酸和头孢唑肟是活性最强的药物。头孢替坦对脆弱拟杆菌的活性与头孢西丁相当，但对脆弱拟杆菌群分离株的活性较低。头孢噻肟的去乙酰代谢产物对其活性的增强作用极小。
相似文献
1
Activity of newer beta-lactam agents against clinical isolates of Bacteroides fragilis and other Bacteroides species.
Antimicrob Agents Chemother. 1987 Dec;31(12):2002-4. doi: 10.1128/AAC.31.12.2002.
2
Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group.
Antimicrob Agents Chemother. 1990 Mar;34(3):479-80. doi: 10.1128/AAC.34.3.479.
3
Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents.
Pathology. 1988 Jul;20(3):260-3. doi: 10.3109/00313028809059504.
4
Newer beta-lactam agents and the Bacteroides fragilis group.
Pharmacotherapy. 1991;11(2 ( Pt 2)):51S-55S.
5
Survey of Bacteroides fragilis group susceptibility patterns in Canada.
Antimicrob Agents Chemother. 1992 Feb;36(2):343-7. doi: 10.1128/AAC.36.2.343.
6
In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group.
J Antimicrob Chemother. 1986 May;17(5):593-603. doi: 10.1093/jac/17.5.593.
7
Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.
J Clin Microbiol. 1988 Nov;26(11):2361-6. doi: 10.1128/jcm.26.11.2361-2366.1988.
8
Cross-resistance to beta-lactam-beta-lactamase inhibitor combinations and clindamycin among cefoxitin-resistant and cefoxitin-susceptible strains of the Bacteroides fragilis group.
Diagn Microbiol Infect Dis. 1993 Oct;17(3):251-6. doi: 10.1016/0732-8893(93)90107-i.
9
The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987.
J Antimicrob Chemother. 1990 Jun;25(6):1011-9. doi: 10.1093/jac/25.6.1011.
10
Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.
Antimicrob Agents Chemother. 1990 Aug;34(8):1546-50. doi: 10.1128/AAC.34.8.1546.
引用本文的文献
1
Longitudinal study of susceptibilities of species of the Bacteroides fragilis group to five antimicrobial agents in three medical centers.
Antimicrob Agents Chemother. 1994 Oct;38(10):2276-9. doi: 10.1128/AAC.38.10.2276.
2
Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.
J Clin Microbiol. 1988 Nov;26(11):2361-6. doi: 10.1128/jcm.26.11.2361-2366.1988.
3
Comparative in vitro antimicrobial susceptibilities of a special panel of 74 Bacteroides fragilis group isolates in Wilkins-Chalgren agar with and without sheep blood.
Antimicrob Agents Chemother. 1989 Mar;33(3):394-5. doi: 10.1128/AAC.33.3.394.
4
5
Spiral gradient endpoint method compared to standard agar dilution for susceptibility testing of anaerobic gram-negative bacilli.
J Clin Microbiol. 1991 May;29(5):975-9. doi: 10.1128/jcm.29.5.975-979.1991.
6
Effect of beta-lactamase inhibitors on the activities of various beta-lactam agents against anaerobic bacteria.
Antimicrob Agents Chemother. 1991 Jun;35(6):1219-24. doi: 10.1128/AAC.35.6.1219.
7
In vitro susceptibilities of the Bacteroides fragilis group to 14 antimicrobial agents in Korea.
Antimicrob Agents Chemother. 1992 Jan;36(1):195-7. doi: 10.1128/AAC.36.1.195.
本文引用的文献
1
A randomized comparison of cefoxitin with or without amikacin and clindamycin plus amikacin in surgical sepsis.
Ann Surg. 1981 Mar;193(3):318-23. doi: 10.1097/00000658-198103000-00011.
2
Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982.
Antimicrob Agents Chemother. 1984 Aug;26(2):145-8. doi: 10.1128/AAC.26.2.145.
3
Risk of infection after penetrating abdominal trauma.
N Engl J Med. 1984 Oct 25;311(17):1065-70. doi: 10.1056/NEJM198410253111701.
4
Prospective, randomized, comparative trials in the therapy for intraabdominal and female genital tract infections.
Rev Infect Dis. 1984 Mar-Apr;6 Suppl 1:S283-92. doi: 10.1093/clinids/6.supplement_1.s283.
5
Antimicrobial activity of desacetylcefotaxime alone and in combination with cefotaxime: evidence of synergy.
Rev Infect Dis. 1982 Sep-Oct;4 Suppl:S366-73. doi: 10.1093/clinids/4.supplement_2.s366.
6
Clinical pharmacokinetics of cefotaxime in patients with normal and reduced renal function.
Rev Infect Dis. 1982 Sep-Oct;4 Suppl:S333-45. doi: 10.1093/clinids/4.supplement_2.s333.
7
Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States.
Antimicrob Agents Chemother. 1985 Nov;28(5):675-7. doi: 10.1128/AAC.28.5.675.
8
Comparative clinical evaluation of ceftizoxime with clindamycin and gentamicin and cefoxitin in the treatment of postcesarean endomyometritis.
Surg Gynecol Obstet. 1985 Dec;161(6):518-22.
9
Randomized prospective study comparing moxalactam and cefoxitin with or without tobramycin for the treatment of serious surgical infections.
Antimicrob Agents Chemother. 1986 Feb;29(2):244-9. doi: 10.1128/AAC.29.2.244.
10
Activity of cefazolin and two beta-lactamase inhibitors, clavulanic acid and sulbactam, against Bacteroides fragilis.
Antimicrob Agents Chemother. 1987 Feb;31(2):321-2. doi: 10.1128/AAC.31.2.321.
Zotero 插件